Cumulus Oncology develops oncology therapies and accelerates drug‑development programmes by creating Sign up to read more
| Allotment | Filed | Share Class | Round Size | Round Type |
|---|---|---|---|---|
2023-12-20 | £9.0M |
| Shareholder | Share class | Shares | Holding |
|---|---|---|---|
| SCOTTISH INVESTMENTS LIMITEDCORP | PREFERRED | 15,800 | 26.8% |
| 8888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 88888888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 888888888888888888 | 8888888888 | 888888 | 8888 |
| 8888888888888 | 88888888 | 888888 |
Companies with the most similar business descriptions.
Persons with significant control are available once you sign up.
Capital raised per employee divides the equity CUMULUS ONCOLOGY LIMITED raised in the last six months by the headcount in its most recent filed accounts. It is a rough read on how capital-intensive the business is: a high figure means the company is raising a lot relative to the number of people it employs, which is typical of hardware, biotech and other research-heavy businesses. Headcount comes from annual accounts and so lags the funding date, often by a year or more.
A share class is a category of shares carrying its own rights over voting, dividends and what happens to the money if the company is sold or wound up. UK companies typically issue Ordinary shares to founders and employees, then create a new Preferred class at each funding round, giving investors priority on proceeds ahead of the Ordinary holders. CUMULUS ONCOLOGY LIMITED has 4 distinct classes on file at Companies House; the rights attached to each are reproduced below as filed.
FULL VOTING RIGHTS, EACH SHARE IS ENTITLED TO ONE VOTE AND EQUALLY FOR ANY DIVIDENDS DECLARED. IN THE EVENT OF A WINDING UP, THE A ORDINARY SHAREHOLDERS WILL RECEIVE THE HIGHER OF THEIR ORIGINAL SUBSCRIPTION PRICE IN, OR THEIR PRORATED SHARE OF SUCH ASSETS OR CONSIDERATION AS FULLY SET OUT IN THE COMPANY'S ARTICLES OF ASSOCIATION. THE A ORDINARY SHARES CAN BE CONVERTED INTO ORDINARY SHARES AT ANY TIME OR AUTOMATICALLY IN ACCORDANCE WITH THE ARTICLES OF ASSOCIATION.
NO RIGHTS TO VOTE OR TO PARTICIPATE IN DIVIDENDS OR DISTRIBUTIONS (INCLUDING IN A WINDING UP). NOT REDEEMABLE
FULL VOTING RIGHTS, EACH SHARE IS ENTITLED TO ONE VOTE, EACH SHARE RANKS EQUALLY FOR ANY DIVIDENDS DECLARED AND EQUALLY FOR ANY DISTRIBUTIONS ON WINDING UP. THE SHARES ARE NOT REDEEMABLE.
These are the directors and secretaries who have left CUMULUS ONCOLOGY LIMITED. A resignation is filed with Companies House on form TM01 and the date below is the date the officer's appointment ended, not the date it was filed. Departures matter for reading a company's history: a founder leaving shortly after a funding round, or several directors resigning at once, is often the visible trace of a change of control or a restructure.
| 8888 |
| 8888888888888 | 88888888 | 888888 | 8888 |
109 more shareholders on file , sign up free to see.